Literature DB >> 23387088

[Chemical ingredient analysis of sediments from both single Radix Aconiti Lateralis decoction and Radix Aconiti Lateralis - Radix Glycyrrhizae decoction by HPLC-MS].

Jin-Ming Zhang1, Ling Li, Fei Gao, Ying Li, Yao He, Chao-Mei Fu.   

Abstract

The chemical ingredients of sediments from single Radix Aconiti Lateralis (Fuzi, in Chinese) decoction and Radix Aconiti Lateralis-Radix Glycyrrhizae (Gancao, in Chinese) decoction were evaluated separately by HPLC-MS for exploring their ingredients difference and discussing the mechanism of toxicity reduction of Fuzi-Gaocao herb-pair, even providing the experimental basis for extracting and purifying process of TCM preparations containing Fuzi-Gancao herb-pair. The sediments samples from single Fuzi decoction (FD) and Fuzi-Gaocao decoction (FGD) were prepared separately firstly. Then these samples were analyzed in the same chromatographic and mass spectrometry condition, estimating their HPLC-MS fingerprint and identifying their compounds by Q-TOFMS. As a result, 28 compounds in sediments samples from FD were obtained, among which 25 compounds and structures were confirmed. Besides, 36 compounds in sediments samples from FGD sample were obtained including 34 confirmed compounds and structures, among which there were 11 compounds from Gancao and 25 compounds from Fuzi. However, according to these confirmed compounds, alkaloids compounds in sediments samples from FGD were significantly different from that in sediments samples from FD. This result showed the fact that there would be some influences on alkaloid compounds in decoction after the combination of Gancao. In this study, the experiment basis of the mechanism of toxicity reduction of Fuzi-Gaocao herb-pair is provided. It also showed that much attention should be paid to the fact that there were great amount of alkaloid compounds, the effective compounds, in the sediments for which a comprehensive utilization in clinic and pharmaceutical process should be noted.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23387088

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  4 in total

1.  An Integrated Gut Microbiota and Network Pharmacology Study on Fuzi-Lizhong Pill for Treating Diarrhea-Predominant Irritable Bowel Syndrome.

Authors:  Zhang Zhen; Lin Xia; Huang You; Zhou Jingwei; Yang Shasha; Wei Xinyi; Lai Wenjing; Zhang Xin; Fu Chaomei
Journal:  Front Pharmacol       Date:  2021-11-30       Impact factor: 5.810

Review 2.  Study on Supramolecules in Traditional Chinese Medicine Decoction.

Authors:  Yuan Gao; Yingying Dong; Qin Guo; Huanhuan Wang; Mei Feng; Zhengshen Yan; Dong Bai
Journal:  Molecules       Date:  2022-05-19       Impact factor: 4.927

3.  Rapid discovery of chemical constituents and absorbed components in rat serum after oral administration of Fuzi-Lizhong pill based on high-throughput HPLC-Q-TOF/MS analysis.

Authors:  Zhen Zhang; Maoyuan Jiang; Xinyi Wei; Jinfeng Shi; Zhao Geng; Shasha Yang; Chaomei Fu; Li Guo
Journal:  Chin Med       Date:  2019-03-01       Impact factor: 5.455

4.  Decoding herbal materials of TCM preparations with the multi-barcode sequencing approach.

Authors:  Qi Yao; Xue Zhu; Maozhen Han; Chaoyun Chen; Wei Li; Hong Bai; Kang Ning
Journal:  Sci Rep       Date:  2022-04-09       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.